Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2020-10-16
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to learn whether the remote weight loss and maintenance classes can lead to similar weight loss compared to the in-person weight loss and maintenance classes that were offered to patients before the COVID-19 pandemic. This study also aims to gather feedback about the program to improve its delivery and patients' experiences.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Study of a Simple Weight Loss Program for Obese Patients With Obstructive Sleep Apnea
NCT00131547
Motivational Interviewing to Promote Healthy Behaviours in Young Adults
NCT05264740
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
NCT04520256
The Effect of Telephone and Video Counseling on Weight Loss and Quality of Life
NCT05276544
A Pilot Study Evaluating a Clinically Managed Weight Loss Program
NCT04290910
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a 26-week, single-centre, mixed retrospective and prospective, observational study evaluating the efficacy of counselling in a remote setting compared to an in-person setting in achieving weight loss among adult patients with obesity enrolled in the behaviour modification program. This study also aims to gather feedback about the program to improve its delivery and patients' experiences.
Approximately 120 patients participating in the behaviour modification program and providing informed consent will be observed in this study. This study involves a prospective and retrospective component. The prospective component will be an observational study of 60 subjects who will receive 26-weeks of weight loss and maintenance counselling in a remote setting and a low-calorie meal replacement as part of their usual care. The retrospective component will involve using historical data from 60 subjects who received 26-weeks of weight loss and maintenance counselling in an in-person setting and a low-calorie meal replacement as part of their usual care.
Parameters measured as part of standard of care at the start and end of the program, such as body weight, blood pressure and lab tests will be collected for analysis of study endpoints. Participants will also be asked to complete a satisfaction survey at the end. There will be no blinding of patients, study investigators, or data analysts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote Weight Loss Behaviour Modification Program with Meal Replacements
This is the prospective study group who will receive 26-weeks of weight loss and maintenance counselling in a remote setting and a low-calorie meal replacement as part of their usual care.
Remote Behaviour Modification Program
The standard of care behaviour modification program for weight loss will be offered virtually due to the COVID-19 pandemic (prospective).
In Person Weight Bahaviour Modification Program with Meal Replacements
This is the retrospective study group who received 26-weeks of weight loss and maintenance counselling in person and a low-calorie meal replacement as part of their usual care.
In Person Behaviour Modification Program
The standard of care behaviour modification program for weight loss was offered in person prior to the COVID-19 pandemic (retrospective).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Behaviour Modification Program
The standard of care behaviour modification program for weight loss will be offered virtually due to the COVID-19 pandemic (prospective).
In Person Behaviour Modification Program
The standard of care behaviour modification program for weight loss was offered in person prior to the COVID-19 pandemic (retrospective).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enrolled in 26-week BCoE behaviour modification program with meal replacements
* Able and willing to provide signed informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Joseph's Healthcare Hamilton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tony Chetty
Associate Professor Pathology and Molecular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tony Chetty, MD
Role: PRINCIPAL_INVESTIGATOR
St. Joseph's Healthcare Hamilton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Remote v In Person Weight Loss
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.